These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Indications and modes of use for interleukin (IL)-1 antagonists in inflammatory dermatosis: a new therapeutic approach to immune-mediated inflammatory diseases]. Lipsker D; Lenormand C Ann Dermatol Venereol; 2012 Jun; 139(6-7):459-67. PubMed ID: 22721478 [TBL] [Abstract][Full Text] [Related]
4. Clinical, biological and sonographic response to IL-1 blockade in adult-onset Still's disease. Priori R; Ceccarelli F; Barone F; Iagnocco A; Valesini G Clin Exp Rheumatol; 2008; 26(5):933-7. PubMed ID: 19032833 [No Abstract] [Full Text] [Related]
5. Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade. Rech J; Ronneberger M; Englbrecht M; Finzel S; Katzenbeisser J; Manger K; Manger B; Schett G Ann Rheum Dis; 2011 Feb; 70(2):390-2. PubMed ID: 20650873 [No Abstract] [Full Text] [Related]
6. Severe systemic inflammatory response syndrome in a patient with adult onset Still's disease treated with the anti-IL1 drug anakinra: a case report. Guignard S; Dien G; Dougados M Clin Exp Rheumatol; 2007; 25(5):758-9. PubMed ID: 18078628 [TBL] [Abstract][Full Text] [Related]
7. Two cases of anakinra-induced neutropenia during auto-inflammatory diseases: drug reintroduction can be successful. Perrin F; Néel A; Graveleau J; Ruellan AL; Masseau A; Hamidou M Presse Med; 2014 Mar; 43(3):319-21. PubMed ID: 24456697 [No Abstract] [Full Text] [Related]
18. Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Aletaha D; Kerschbaumer A; Kastrati K; Dejaco C; Dougados M; McInnes IB; Sattar N; Stamm TA; Takeuchi T; Trauner M; van der Heijde D; Voshaar M; Winthrop KL; Ravelli A; Betteridge N; Burmester GR; Bijlsma JW; Bykerk V; Caporali R; Choy EH; Codreanu C; Combe B; Crow MK; de Wit M; Emery P; Fleischmann RM; Gabay C; Hetland ML; Hyrich KL; Iagnocco A; Isaacs JD; Kremer JM; Mariette X; Merkel PA; Mysler EF; Nash P; Nurmohamed MT; Pavelka K; Poor G; Rubbert-Roth A; Schulze-Koops H; Strangfeld A; Tanaka Y; Smolen JS Ann Rheum Dis; 2023 Jun; 82(6):773-787. PubMed ID: 35953263 [TBL] [Abstract][Full Text] [Related]
19. A case of bilateral trochleitis in adult-onset Still's disease. Gutmark R; Eliasieh K; Rivera-Michlig R Semin Arthritis Rheum; 2014 Apr; 43(5):689-91. PubMed ID: 24176730 [TBL] [Abstract][Full Text] [Related]
20. Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome. de Koning HD; Schalkwijk J; van der Ven-Jongekrijg J; Stoffels M; van der Meer JW; Simon A Ann Rheum Dis; 2013 Oct; 72(10):1634-8. PubMed ID: 23087179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]